A peptide hormone
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Gastrin I (human)

Item No. 24457

Technical Information
Formal Name
5-oxo-L-prolylglycyl-L-prolyl-L-tryptophyl-L-leucyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-α-glutamyl-L-alanyl-L-tyrosylglycyl-L-tryptophyl-L-methionyl-L-α-aspartyl-L-phenylalaninamide
CAS Number
10047-33-3
Synonyms
  • Gastrin I (1-17) (human)
  • Gastrin Heptadecapeptide I (human)
Molecular Formula
C97H124N20O31S
Formula Weight
Purity
≥95%
A lyophilized powder
1% NH3 (Aqueous): 1 mg/mlFormic Acid: 1 mg/ml
SMILES
O=C([C@@H]1CCCN1C(CNC([C@@H]2CCC(N2)=O)=O)=O)N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H](CC3=CC=C(O)C=C3)C(NCC(N[C@H](C(N[C@H](C(N[C@@H](CC(O)=O)C(N[C@H](C(N)=O)CC4=CC=CC=C4)=O)=O)CCSC)=O)CC5=CNC6=C5C=CC=C6)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC7=CNC8=C7C=CC=C8
InChi Code
InChI=1S/C97H124N20O31S/c1-49(2)39-68(114-95(146)71(43-54-46-100-59-18-11-9-16-57(54)59)116-97(148)73-19-12-37-117(73)76(121)48-102-85(136)60-24-30-74(119)104-60)93(144)110-65(29-35-81(130)131)91(142)109-64(28-34-80(128)129)90(141)108-63(27-33-79(126)127)89(140)107-62(26-32-78(124)125)88(139)106-61(25-31-77(122)123)87(138)103-50(3)84(135)113-69(41-52-20-22-55(118)23-21-52)86(137)101-47-75(120)105-70(42-53-45-99-58-17-10-8-15-56(53)58)94(145)111-66(36-38-149-4)92(143)115-72(44-82(132)133)96(147)112-67(83(98)134)40-51-13-6-5-7-14-51/h5-11,13-18,20-23,45-46,49-50,60-73,99-100,118H,12,19,24-44,47-48H2,1-4H3,(H2,98,134)(H,101,137)(H,102,136)(H,103,138)(H,104,119)(H,105,120)(H,106,139)(H,107,140)(H,108,141)(H,109,142)(H,110,144)(H,111,145)(H,112,147)(H,113,135)(H,114,146)(H,115,143)(H,116,148)(H,122,123)(H,124,125)(H,126,127)(H,128,129)(H,130,131)(H,132,133)/t50-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-/m0/s1
InChi Key
GKDWRERMBNGKCZ-RNXBIMIWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Gastrin I is an endogenous, gastrointestinal peptide hormone that binds to cholecystokinin (CCK) receptors on human gastric leiomyosarcoma cells (IC50 = 0.9 nM) and in guinea pig gallbladder and pancreatic tissue (IC50s = 1.7 and 2.5 μM, respectively).1,2 It increases levels of cytosolic calcium in isolated rabbit stomach parietal cells (EC50 = 11 nM) and stimulates pepsinogen secretion by isolated human peptic cells (ED50 = 30 nM).3,4 Gastrin I increases histidine decarboxylase (HDC) activity ex vivo in fundic stomach mucosa homogenate and increases gastric acid secretion in vivo in rats when administered at a dose of 1 nmol/kg/h.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Miller, L.J. Characterization of cholecystokinin receptors on human gastric smooth muscle tumors. Am. J. Physiol. 247(4 Pt 1), G402-G410 (1984).

    2. von Schrenck, T., Moran, T.H., Heinz-Erian, P., et alCholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: A comparative study. Am. J. Physiol. 255(4 Pt 1), G512-G521 (1988).

    3. Letari, O., Mennuni, L., Colombo, S., et alCytosolic Ca2+ evaluation in rabbit parietal cells: A novel method to screen gastrin receptor antagonists. Eur. J. Pharmacol. 306(1-3), 325-333 (1996).

    4. Lanas, A.I., Anderson, J.W., Uemura, N., et alEffects of cholinergic, histaminergic, and peptidergic stimulation on pepsinogen secretion by isolated human peptic cells. Scand. J. Gastroenterol. 29(8), 678-683 (1994).

    5. Kawabata, S., Kanayama, S., Shinomura, Y., et alEffect of cholecystokinin receptor antagonists, MK-329 and L-365,260, on cholecystokinin-induced acid secretion and histidine decarboxylase activity in the rat. Regul. Pept. 35(1), 1-10 (1991).